Total Payments
$4,811
2024 Payments
$1,229
Companies
34
Transactions
194
Medicare Patients
21,510
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$4,463 (92.8%)
Education$347.46 (7.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,463 | 190 | 92.8% |
| Education | $347.46 | 4 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,099 | 55 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $414.23 | 17 | $0 (2024) |
| PFIZER INC. | $409.49 | 13 | $0 (2024) |
| Dermavant Sciences, Inc. | $395.31 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $348.41 | 17 | $0 (2022) |
| Janssen Biotech, Inc. | $310.04 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $282.27 | 6 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $248.60 | 7 | $0 (2024) |
| Amgen Inc. | $190.71 | 8 | $0 (2024) |
| GENZYME CORPORATION | $171.28 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,229 | 40 | PFIZER INC. ($255.36) |
| 2023 | $740.02 | 28 | Dermavant Sciences, Inc. ($166.62) |
| 2022 | $706.78 | 25 | Regeneron Healthcare Solutions, Inc. ($150.00) |
| 2021 | $469.96 | 20 | AbbVie Inc. ($159.47) |
| 2019 | $631.60 | 30 | AbbVie, Inc. ($201.46) |
| 2018 | $567.45 | 28 | AbbVie, Inc. ($181.18) |
| 2017 | $465.93 | 23 | AbbVie, Inc. ($81.05) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 11/12/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $198.51 | General |
| Category: Inflammation & Immunology | ||||||
| 11/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $179.06 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/08/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $16.46 | General |
| 10/01/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: DERMATOLOGY | ||||||
| 07/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Dermatology | ||||||
| 07/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 07/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,962 | 8,952 | $1.3M | $498,007 |
| 2022 | 36 | 5,807 | 9,038 | $1.2M | $474,761 |
| 2021 | 33 | 5,190 | 8,335 | $1.1M | $445,574 |
| 2020 | 32 | 4,551 | 6,995 | $1.0M | $406,013 |
Total Patients
21,510
Total Services
33,320
Medicare Billing
$1.8M
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,164 | 1,443 | $191,848 | $77,668 | 40.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 133 | 149 | $160,987 | $66,044 | 41.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 80 | 139 | $84,424 | $43,241 | 51.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 473 | 781 | $116,447 | $41,069 | 35.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 494 | 565 | $94,676 | $39,642 | 41.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 865 | 1,034 | $102,473 | $34,551 | 33.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 492 | 579 | $86,820 | $34,328 | 39.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 75 | 90 | $52,794 | $26,799 | 50.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 532 | 597 | $49,616 | $20,485 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 199 | 199 | $32,819 | $13,104 | 39.9% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 90 | 92 | $38,660 | $11,404 | 29.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 576 | 2,258 | $61,643 | $10,427 | 16.9% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 18 | 18 | $27,783 | $9,726 | 35.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 75 | 88 | $18,121 | $8,431 | 46.5% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 52 | 53 | $20,669 | $8,426 | 40.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 39 | 40 | $17,937 | $6,840 | 38.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 39 | 48 | $12,694 | $6,038 | 47.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 108 | 154 | $11,450 | $5,560 | 48.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 27 | 27 | $11,144 | $4,210 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 49 | $9,221 | $3,631 | 39.4% |
| 12041 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less | Office | 2023 | 20 | 20 | $7,835 | $3,169 | 40.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 69 | 69 | $7,353 | $3,021 | 41.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 19 | 19 | $8,890 | $2,805 | 31.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 31 | 33 | $6,457 | $2,565 | 39.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 31 | $5,758 | $2,504 | 43.5% |
About Dr. Sara Risner-Rumohr, M.D
Dr. Sara Risner-Rumohr, M.D is a MOHS-Micrographic Surgery healthcare provider based in Flagstaff, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1922319334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Risner-Rumohr, M.D has received a total of $4,811 in payments from pharmaceutical and medical device companies, with $1,229 received in 2024. These payments were reported across 194 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,463).
As a Medicare-enrolled provider, Risner-Rumohr has provided services to 21,510 Medicare beneficiaries, totaling 33,320 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Flagstaff, AZ
- Active Since 06/30/2010
- Last Updated 01/28/2021
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1922319334
Products in Payments
- Humira (Biological) $449.64
- VTAMA (Drug) $395.31
- DUPIXENT (Biological) $391.49
- SKYRIZI (Biological) $336.87
- COSENTYX (Biological) $309.24
- CIBINQO (Drug) $219.72
- EUCRISA (Drug) $189.77
- BLU-U (Medical Supply) $164.26
- ILUMYA (Biological) $125.56
- RINVOQ (Biological) $119.74
- Enbrel (Biological) $119.69
- HUMIRA (Biological) $114.02
- Tremfya (Drug) $99.99
- SILIQ (Drug) $96.07
- TREMFYA (Drug) $94.77
- REMICADE (Biological) $85.69
- JUBLIA (Drug) $83.46
- Otezla (Drug) $71.02
- DUOBRII (Drug) $69.07
- BOTOX (Biological) $64.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.